1. BoNT-As for adult spasticity and cervical dystonia: Cost-effectiveness analysis and the cost of response in the United Kingdom. (January 2021) Authors: Johnston, Karissa; Danchenko, Natalya; Bolatova, Talshyn; Whalen, John Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis. (June 2019) Authors: Guyot, Patricia; Kalyvas, Chrysostomos; Mamane, Carole; Danchenko, Natalya Journal: Journal of child neurology Issue: Volume 34:Number 7(2019:Jul.) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical and Economic Outcomes of Adult Limb Spasticity Treatment with Botulinum Toxin Type A Products: A Single-Center, Non-Interventional Study. (July 2022) Authors: Bezzina, Clive; Degtiar, Vadim; Danchenko, Natalya; Calvi-Gries, Francoise; Davis, Benjamin; Engmann, Emanuel; Guyon, Elodie; Lecanuet, Sophie; Whalen, John Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Refractory Neurogenic Detrusor Overactivity: An Indirect Treatment Comparison. (July 2022) Authors: Danchenko, Natalya; Fahrbach, Kyle; Freitag, Andreas; Tarpey, Jialu; Whalen, John Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada. (2nd June 2020) Authors: Johnston, Karissa; Danchenko, Natalya; Hansen, Ryan; Dinet, Jerome; Liovas, Anna; Armstrong, Ava; Bains, Savreet; Sullivan, Sean D. Journal: Journal of medical economics Issue: Volume 23:Number 6(2020) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness of BoNT-A products for treatment of pediatric spasticity in the United Kingdom. (January 2021) Authors: Danchenko, Natalya; Johnston, Karissa; Bolatova, Talshyn; Whalen, John Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant. (2nd January 2021) Authors: Atsou, Kokuvi; Ereshefsky, Larry; Brignone, Mélanie; Danchenko, Natalya; Diamand, Françoise; Mucha, Lisa; Touya, Maëlys; Becker, Russell; François, Clément Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 21:Number 1(2021) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. (4th May 2017) Authors: Soini, Erkki; Hallinen, Taru; Brignone, Mélanie; Campbell, Rosanne; Diamand, Françoise; Cure, Sandrine; Aalto-Setälä, Maria; Danchenko, Natalya; Koponen, Hannu; Kolasa, Katarzyna Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 17:Number 3(2017) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Economic benefits of adult upper limb spasticity treatment with abobotulinumtoxinA compared with onabotulinumtoxinA or incobotulinumtoxinA: Analysis of a real-life setting in France. (December 2018) Authors: Schnitzler, Alexis; Rousset, Laure; de Oliveira, Laurence; Velickovic, Diana; Danchenko, Natalya Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Economic outcomes in real-world use of botulinum toxin-A products for adult patients with upper limb spasticity: A UK perspective. (January 2021) Authors: Turner-Stokes, Lynne; Ashford, Stephen; Jacinto, Jorge; Fheodoroff, Klemens; Danchenko, Natalya; Maisonobe, Pascal; Williams, Michael; Whalen, John Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗